Skip to main content

Table 1 Characteristics for data abstraction

From: Rapid antigen-based and rapid molecular tests for the detection of SARS-CoV-2: a rapid review with network meta-analysis of diagnostic test accuracy studies

Group

Data abstracted

Participant characteristics

Symptom status (symptomatic, asymptomatic); Duration of symptoms (in days); Age of test recipient; General public vs. Healthcare workers; Proportion of females/women (i.e., sex and gender of person being tested); Ethnicity; COVID-19 Vaccination status; Vaccine type; Number of vaccinations for COVID-19; Time of last vaccination

Test characteristics

Test name; Manufacturer; Sample type (e.g., saliva, nasopharyngeal swab, buccal/tongue, nasal); Sample condition; Time required for a test; Sample storage; Reference Standard; Test operator (e.g., nurse, self-testing); Who interpreted the results (e.g., nurse, self-testing); 2 × 2 table; Sensitivity, specificity, positive predicted value, negative predictive value with corresponding uncertainty measures (e.g., 95% CI)

Study characteristics

Year of publication; Journal name; Country where study completed; Study design; Study setting (school, community, health facilities [e.g., hospital]); Setting of participant recruitment; Study duration; Recruitment dates